A Rare Case of Primary Malignant Melanoma Presenting with Lower Extremity Weakness

Ehsan Alimohammadi; Guive Sharifi

doi:10.1055/s-0040-1708081

Indian Journal of Neurosurgery, Table of Contents

CC BY-NC-ND 4.0 · Indian Journal of Neurosurgery 2020; 9(03): 208-212
DOI: 10.1055/s-0040-1708081

Case Report

A Rare Case of Primary Malignant Melanoma Presenting with Lower Extremity Weakness

Authors

Ehsan Alimohammadi

¹Department of Neurosurgery, Kermanshah University of Medical Sciences, Imam Reza Hospital, Kermanshah, Iran
Guive Sharifi

²Department of Neurosurgery, Shahid Beheshti University of Medical Sciences, Loghman Hakim Hospital, Tehran, Iran

Abstract

The authors report a pathologically confirmed case of primary malignant melanoma located in the intradural lumbosacral area, which is extremely rare due to its atypical location and manifestation. However rare, primary malignant melanoma could present as an intradural tumor and cause neurological deficit.

keywords

intramedullary tumor - melanoma - retroperitoneum

Full Text

References

References
1 Li YP, Zhang HZ, She L. et al. Primary extramedullary spinal melanoma mimicking spinal meningioma: a case report and literature review. Oncol Lett 2014; 8 (01) 339-344
2 Fuld AD, Speck ME, Harris BT. et al. Primary melanoma of the spinal cord: a case report, molecular footprint, and review of the literature. J Clin Oncol 2011; 29 (17) e499-e502
3 Pappenheim E, Bhattacharji SK. Primary melanoma of the central nervous system. Clinical-pathological report of a case, with survey and discussion of the literature. Arch Neurol 1962; 7: 101-113
4 Farrokh D, Fransen P, Faverly D. MR findings of a primary intramedullary malignant melanoma: case report and literature review. Am J Neuroradiol 2001; 22 (10) 1864-1866
5 Sivendran S, Glodny B, Pan M, Merad M, Saenger Y. Melanoma immunotherapy. Mt Sinai J Med 2010; 77 (06) 620-642
6 Ko JM, Fisher DE. A new era: melanoma genetics and therapeutics. J Pathol 2011; 223 (02) 241-250
7 Jungbluth AA, Busam KJ, Gerald WL. et al. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 1998; 22 (05) 595-602
8 Larson III TC, Houser OW, Onofrio BM, Piepgras DG. Primary spinal melanoma. J Neurosurg 1987; 66 (01) 47-49
9 Hayward RD. Malignant melanoma and the central nervous system. A guide for classification based on the clinical findings. J Neurol Neurosurg Psychiatry 1976; 39 (06) 526-530
10 Nishihara M, Sasayama T, Kondoh T, Tanaka K, Kohmura E, Kudo H. Long-term survival after surgical resection of primary spinal malignant melanoma. Neurol Med Chir (Tokyo) 2009; 49 (11) 546-548
11 Chamberlain MC, Tredway TL. Adult primary intradural spinal cord tumors: a review. Curr Neurol Neurosci Rep 2011; 11 (03) 320-328
12 Rager EL, Bridgeford EP, Ollila DW. Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment. Am Fam Physician 2005; 72 (02) 269-276
13 Yamaguchi T, Shioaki Y, Koide K. et al. A case of primary malignant melanoma of the esophagus and analysis of 193 patients in Japan [article in Japanese]. Nippon Shokakibyo Gakkai Zasshi 2004; 101 (10) 1087-1094
14 Greco Crasto S, Soffietti R, Bradac GB, Boldorini R. Primitive cerebral melanoma: case report and review of the literature. Surg Neurol 2001; 55 (03) 163-168, discussion 168
15 Cuevas LM, Daud AI. Immunotherapy for melanoma. SeminCutan Med Surg 2018; 37 (02) 127-131
16 Garbe C, Eigentler TK, Keilholz U, Hauschild A, Kirkwood JM. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist 2011; 16 (01) 5-24
17 Liubinas SV, Maartens N, Drummond KJ. Primary melanocytic neoplasms of the central nervous system. J Clin Neurosci 2010; 17 (10) 1227-1232